Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Non-cash Items (2016 - 2019)

Usana Health Sciences (USNA) has disclosed Non-cash Items for 9 consecutive years, with $13.1 million as the latest value for Q4 2019.

  • On a quarterly basis, Non-cash Items fell 79.66% to $13.1 million in Q4 2019 year-over-year; TTM through Dec 2019 was $13.1 million, a 79.66% decrease, with the full-year FY2019 number at $13.1 million, up 3879.03% from a year prior.
  • Non-cash Items was $13.1 million for Q4 2019 at Usana Health Sciences, down from $64.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $101.8 million in Q4 2015 to a low of $58000.0 in Q3 2015.
  • A 5-year average of $56.1 million and a median of $64.4 million in 2018 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: surged 19352561.6% in 2015, then tumbled 79.66% in 2019.
  • Usana Health Sciences' Non-cash Items stood at $101.8 million in 2015, then plummeted by 64.47% to $36.2 million in 2016, then dropped by 26.17% to $26.7 million in 2017, then skyrocketed by 141.02% to $64.4 million in 2018, then crashed by 79.66% to $13.1 million in 2019.
  • Per Business Quant, the three most recent readings for USNA's Non-cash Items are $13.1 million (Q4 2019), $64.4 million (Q4 2018), and $26.7 million (Q4 2017).